A prospective, single-blinded (rater-blinded), randomized, parallel group study of the efficacy of Quetiapine XR in the treatment of patients with Acute Stress Disorder (DSM-VI 308.3)

Trial Profile

A prospective, single-blinded (rater-blinded), randomized, parallel group study of the efficacy of Quetiapine XR in the treatment of patients with Acute Stress Disorder (DSM-VI 308.3)

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Feb 2013

At a glance

  • Drugs Quetiapine (Primary) ; Mirtazapine
  • Indications Acute traumatic stress disorders
  • Focus Therapeutic Use
  • Acronyms QSR-ASD
  • Most Recent Events

    • 31 Dec 2012 Status changed from recruiting to completed as reported by EudraCT.
    • 06 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top